Yasmin does not cause more side-effects than other contraceptive pills

There is an increased risk of blood clots in women taking contraceptive pills. This risk has been known since contraceptive pills entered the market in the 1960s, which was an important step in the development of contraception for women. The contraceptive pill Yasmin(R) entered the Danish market in 2001. Since then, the Danish Medicines Agency has monitored adverse reactions from Yasmin(R) and assessed Yasmin(R)'s adverse drug reaction profile in relation to other contraceptive pills of the combination type. The Danish Medicines Agency assesses that there are not more adverse reactions, including blood clots, associated with Yasmin(R) compared with other contraceptive pills of the same...

Want to see the full article?

• Purchase this article for only $3.00